Biovail Tiazac Market Share Is Significant Enough To Be Reference Drug - FDA
Executive Summary
Forest/Biovail's Tiazac extended-release diltiazem will be relisted in the Orange Book as a reference listed drug, allowing submission of ANDAs for the brand.